Knockdown of CD24 or Siglec10, as well as using CD24 monoclonal antibodies to block the interaction of CD24 with Siglec10, significantly enhances macrophage phagocytosis of all CD24-expressing human tumor cells. This evidence concerns the gene CD24 and neoplasm.